Tikun Olam

Tikun Olam is an Israeli company that grows and supplies medical cannabis and medical cannabis products.

Health Tech & Life Sciences
Acquired by Cannbit
Public Nof HaGalil, Israel Founded 2006
Last updated 2026-08-22
Total raised
—
Stage
Public
Founded
2006
Headcount
4
HQ
Nof HaGalil, Israel
Sector
Health Tech & Life Sciences

About

Tikun Olam is an Israeli company that specializes in the research, cultivation, and supply of medical cannabis. They are recognized as a pioneer in the field of modern medical cannabis, operating under a license from the Israel Ministry of Health. The company focuses on developing proprietary cannabis strains and standardized products with precise dosages, backed by extensive clinical research and patient feedback. Their products are designed to address various conditions such as pain, sleep, neurological balance, and gastrointestinal issues. Tikun Olam was acquired by Cannbit Pharmaceuticals in 2019 and now operates as Tikun Olam-Cannbit, Israel's leading medical cannabis brand. In April 2023, Tikun Olam announced it would cease cultivation operations and lay off dozens of employees, focusing on being a marketing brand for products from third-party farms.

Headcount over time

4 employees (2026-09) · 1 point
4 4 2026-09

Offices

Nof HaGalil, Israel · HQ / main office
Show all offices (2 more)
  • Kfar Yehoshua, Israel
  • Neot HaKikar, Israel

Q&A

What is Tikun Olam's primary business?
Tikun Olam specializes in breeding proprietary cannabis strains and developing standardized, accurately dosed medical cannabis products. The company also operates Tikun Olam Care, a professional cannabis nursing clinic.
When was Tikun Olam founded?
Tikun Olam was founded in January 2006.
How many employees does Tikun Olam have?
Tikun Olam has 11-50 employees.
What is Tikun Olam's current status?
Tikun Olam is currently active and is a public company. It was acquired by Cannbit Pharmaceuticals in November 2019.
What was the acquisition value of Tikun Olam by Cannbit Pharmaceuticals?
In early 2020, Cannbit Pharmaceuticals acquired Tikun Olam for $23 million, in addition to 5% of its shares and other amounts based on the company's success.
What is Tikun Olam's primary sector?
Tikun Olam's primary sector is Health Tech & Life Sciences, specifically focusing on Medical Cannabis.
Where is Tikun Olam headquartered?
Tikun Olam is headquartered in Nof HaGalil, Israel.
What is Tikun Olam's market capitalization?
Tikun Olam has a market capitalization of $6,798,473.

Team · 9

Avinoam Sapir
General Manager of Tikun Olam-Cannbit
Ronen Elad
Chief Executive Officer and Chairman
Sivan Urail
Accountant
Klein Tony Hanan
Chief Financial Officer
Lihi Bar-Lev Shleider
Head Researcher
Shani Carni Ph.D.
Head Pharmacist - Q.P.
Erez Navon
Director
Prof. Yitzhak Ashkenazi
Director
Dan Rafael Engel
Director

Tags

biotechnologycropspharmaceuticalscannabisbreedingagtechmedical-cannabiscancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitetikunolam.com/
LinkedInlinkedin.com/company/12644267
Facebookfacebook.com/TikunOlamUSA
YouTubeyoutube.com/user/TikunOlamLTD
Instagraminstagram.com/tikun_olam

Identifiers & details

Legal nameTikun Olam-Cannbit Pharmaceuticals Ltd.
Founded2006-1
Employees (exact)4
OfficesKfar Yehoshua; Neot HaKikar
Market cap$6.8M
Status reasonAcquired by Cannbit on Nov, 2019

Acquisitions & public offerings

Acquired by Cannbit 2019-11 $23.0M

Radar intelligence

Patents

EPO5

Publications (Crossref)

Works1

Web history (Wayback)

Domaintikunolam.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)512101460
Statusפעילה
Corp typeישראלית חברה ציבורית
Incorporated1995-01-31
Purposeלעסוק בסוגי עיסוק שפורטו בתקנון
Liabilityמוגבלת
In violation (unfiled)no
Active charges / liens0
Registry events3 — other (1), people (1), violation (1)
Registered addressדרך יצחק רבין 2 פתח תקווה

Recent registry events

DateEvent
2026-04-28עדכון כתובת ו/או מען דיגיטלי
2026-04-28עדכון בעלי תפקידים
2026-05-26עדכון הפרה